Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Blood (2017) 130 (Supplement 1): 632.

https://doi.org/10.1182/blood.V130.Suppl_1.632.632

Published: 2017

Journal Articles

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

Olga Blau, MD PhD, Irina Martynkevich, MD PhD, Franziska Behrenbeck, Claudia D. Baldus, MD, Ekaterina Motiko, Sergei Voloshin, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dorken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2017) 130 (Supplement 1): 5111.

https://doi.org/10.1182/blood.V130.Suppl_1.5111.5111

Published: 2017

Journal Articles

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

Martin Szyska, PhD, Stefanie Herda, PhD, Stefanie Althoff, Andreas Heimann, Tra My Dang, Bernd Dörken, MD PhD, Thomas Blankenstein, Il-Kang Na, MD

Blood (2016) 128 (22): 2162.

https://doi.org/10.1182/blood.V128.22.2162.2162

Published: 2016

Journal Articles

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Olga Blau, MD PhD, Franziska Behrenbeck, Nikola Suckert, Lars R. Fransecky, MD, Claudia D. Baldus, MD, Renate Arnold, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2016) 128 (22): 2891.

https://doi.org/10.1182/blood.V128.22.2891.2891

Published: 2016

Journal Articles

Grouping of Genetic Risk By the European Leukemia Net Classification Predicts Overall Survival and Relapse Incidence in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Philipp G. Hemmati, MD, Theis Terwey, MD, Il-Kang Na, MD, Christian Jehn, MD, Lam G. Vuong, PhD, Philipp le Coutre, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2015) 126 (23): 2012.

https://doi.org/10.1182/blood.V126.23.2012.2012

Published: 2015

Journal Articles

Elevated ROS Levels in Response to CD20-Targeting Enhance Senescence Entry after Immunochemotherapy in Human B-Cell Lymphoma

J. Henry M. Däbritz, MD, Yong Yu, Maja Milanovic, PhD, Jan R. Dörr, Andreas M. Kaufmann, MD, Mathias T. Rosenfeldt, MD, Bernd Dörken, MD PhD, Clemens A. Schmitt, MD

Blood (2014) 124 (21): 2240.

https://doi.org/10.1182/blood.V124.21.2240.2240

Published: 2014

Journal Articles

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

Jaspal S Kaeda, PhD, Simone Bonecker, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, Bernd Dörken, MD, Ilana Zalcberg, Philipp le Coutre, MD

Blood (2014) 124 (21): 4533.

https://doi.org/10.1182/blood.V124.21.4533.4533

Published: 2014

Journal Articles

Frequency of a Highly Polymorphic Variant, S36N GFI1 , Is Increased in CML Patients

Jaspal S Kaeda, PhD, Leila Amini, BSc, Concetta Quintarelli, PhD, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, MD, Fabrizio Pane, MD, Bernd Dörken, MD, Philipp le Coutre, MD

Blood (2014) 124 (21): 3157.

https://doi.org/10.1182/blood.V124.21.3157.3157

Published: 2014

Journal Articles

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Rimma Berenstein, Olga Blau, MD PhD, Axel Nogai, MD, Marlies Wächter, Martin Schmidt-Hieber, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2014) 124 (21): 3357.

https://doi.org/10.1182/blood.V124.21.3357.3357

Published: 2014

Journal Articles

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Il-Kang Na, MD, Philipp le Coutre, MD, Christian F. Jehn, MD, Lam G. Vuong, PhD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2014) 124 (21): 2569.

https://doi.org/10.1182/blood.V124.21.2569.2569

Published: 2014

Journal Articles

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

Olga Blau, MD PhD, Ekaterina Slonova, Rimma Berenstein, Axel Nogai, MD, Kathrin Rieger, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2014) 124 (21): 2576.

https://doi.org/10.1182/blood.V124.21.2576.2576

Published: 2014

Journal Articles

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Jaspal S Kaeda, PhD, Jackline Ayres-Silva, Leila Amini, BSc, Iris von Wunsch-Rolshoven, Frauke Ringel, PhD, Michaela Schwarz, MD, Bernd Dörken, MD, Ilana Zalcberg, Philipp le Coutre, MD

Blood (2014) 124 (21): 1868.

https://doi.org/10.1182/blood.V124.21.1868.1868

Published: 2014

Journal Articles

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Anne Flörcken, MD, Schneider Tanja, MD, Anju Singh, MD, Seval Türkmen, MD, Burmeister Thomas, MD PhD, Joannis Anagnostopoulos, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Jörg Westermann, MD PhD

Blood (2014) 124 (21): 1006.

https://doi.org/10.1182/blood.V124.21.1006.1006

Published: 2014

Journal Articles

Aberrant Expression Of miRNA and mRNA Of Cell Cycle and Adhesion-Related Genes In Bone Marrow Stroma Cells Derived From Patients With Multiple Myeloma

Rimma Berenstein, Blau Igor Wolfgang, MD, PhD, Axel Nogai, MD, Marlies Wächter, Antonio Pezzutto, MD, PhD, Bernd Dörken, MD, PhD, Olga Blau, MD, PhD

Blood (2013) 122 (21): 3149.

https://doi.org/10.1182/blood.V122.21.3149.3149

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status

Philipp Hemmati, MD, Theis H. Terwey, MD, Lam G. Vuong, PhD, Philipp D le Coutre, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2013) 122 (21): 2104.

https://doi.org/10.1182/blood.V122.21.2104.2104

Published: 2013

Journal Articles

DNMT3A Mutations In AML: Incidence, Prognostic Influence and Association With Other Molecular Markers

Igor Wolfgang Blau, MD, PhD, Rimma Berenstein, Claudia D. Baldus, MD, PhD, Sophie Schlabitz, Asiye Kar, Ruhiye Cay, Annette Sindram, Claudia Seide, Antonio Pezzutto, Bernd Dörken, MD, PhD, Olga Blau, MD, PhD

Blood (2013) 122 (21): 2627.

https://doi.org/10.1182/blood.V122.21.2627.2627

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

Philipp G. Hemmati, MD, Gero Massenkeil, MD, Theis H. Terwey, MD, Stefan Neuburger, MD, Philipp le Coutre, MD, Lam Vuong, MD, Bernd Dorken, MD, Renate Arnold, MD

Blood (2007) 110 (11): 3020.

https://doi.org/10.1182/blood.V110.11.3020.3020

Published: 2007

Journal Articles

A Novel Notch Pathway Inhibitor Blocks Osteoclast Activity and Synergistically Induces Apoptosis with the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cells.

Franziska Jundt, MD, Rolf Schwarzer, Phd, Martin Kaiser, MD, Oezlem Acikgoez, MD, Ulrike Heider, MD, Stephan Mathas, MD, Robert Preissner, Phd, Orhan Sezer, MD, Bernd Dorken, MD

Blood (2007) 110 (11): 1522.

https://doi.org/10.1182/blood.V110.11.1522.1522

Published: 2007

Journal Articles

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Theis H. Terwey, MD, Gero Massenkeil, MD, Ingo Tamm, MD, Christoph Lutz, MD, Philipp Hemmati, MD, Stefan Neuburger, MD, Bernd Dorken, MD, Renate Arnold, MD

Blood (2006) 108 (11): 3004.

https://doi.org/10.1182/blood.V108.11.3004.3004

Published: 2006

Journal Articles

Anti Leukemic T Cells in Myeloid Neoplasia: Abnormal Cytokine Secretion Patterns May Prevent Immunological Detection and Possibly Reflect Functional Impairment.

Jörg Westermann, MD, Antje van Lessen, Theis Terwey, MD, Philipp Le Coutre, MD, Gökben Baskaynak, MD, Renate Arnold, MD, Bernd Dorken, MD, Antonio Pezzutto, MD

Blood (2006) 108 (11): 1740.

https://doi.org/10.1182/blood.V108.11.1740.1740

Published: 2006

NARROW

Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy

Prognostic Impact of Distinct Combinations of Molecular Mutations in AML Patients. Results of Two-Center International Cooperation Study

A Novel Bioluminescent Mouse Model for Optimization of Adoptive T Cell Therapy

DNMT3A Mutations in AML Patients: Prognostic Impact and Comparative Analysis of Mutations Burden in Diagnostic Samples, after Standard Therapy, and after Allogeneic Stem Cell Transplantation

Grouping of Genetic Risk By the European Leukemia Net Classification Predicts Overall Survival and Relapse Incidence in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Elevated ROS Levels in Response to CD20-Targeting Enhance Senescence Entry after Immunochemotherapy in Human B-Cell Lymphoma

MSI2 and TGFβR1 Expression Levels in CML Patients and Hematopoietic Cell Lines

Frequency of a Highly Polymorphic Variant, S36N GFI1 , Is Increased in CML Patients

Multiple Myeloma Cells Induce Mitochondrial Stress Response in Bone Marrow Mesenchymal Stromal Cells

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

MSI2 and HOXA9 Expression Is Significantly Increased in Patients with Primary Myelofibrosis

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Aberrant Expression Of miRNA and mRNA Of Cell Cycle and Adhesion-Related Genes In Bone Marrow Stroma Cells Derived From Patients With Multiple Myeloma

Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status

DNMT3A Mutations In AML: Incidence, Prognostic Influence and Association With Other Molecular Markers

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

A Novel Notch Pathway Inhibitor Blocks Osteoclast Activity and Synergistically Induces Apoptosis with the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cells.

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Anti Leukemic T Cells in Myeloid Neoplasia: Abnormal Cytokine Secretion Patterns May Prevent Immunological Detection and Possibly Reflect Functional Impairment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only